Scarica l'app Stockscreener
73.58
0.66%
0.355
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$73.23
Aprire:
$72.55
Volume 24 ore:
531.43K
Relative Volume:
0.37
Capitalizzazione di mercato:
$8.39B
Reddito:
$13.18B
Utile/perdita netta:
$419.00M
Rapporto P/E:
22.50
EPS:
3.2704
Flusso di cassa netto:
$521.00M
1 W Prestazione:
+1.52%
1M Prestazione:
-6.50%
6M Prestazione:
+0.42%
1 anno Prestazione:
+2.26%
Intervallo 1D:
$71.66
$73.79
Intervallo di 1 settimana:
$71.50
$73.99
Portata 52W:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
73.62 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
761.30 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
264.60 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.46 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.51 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-16 | Iniziato | BTIG Research | Neutral |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-02-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein stock (US42548G1040): Q1 2026 results and outlook update put margins in the spotlight - AD HOC NEWS
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance - Yahoo Finance
Henry Schein Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Henry Schein stock (US42548G1040): Q1 results and outlook update draw investor focus - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution - DirectorsTalk Interviews
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness - MarketBeat
A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance - Sahm
Citigroup initiates coverage of Henry Schein (HSIC) with buy recommendation - MSN
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail
LONE PEAK VALUE FUND's Henry Schein Inc(HSIC) Holding History - GuruFocus
An Insider Of Henry Schein Picks Up 100% More Stock - simplywall.st
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - Yahoo Finance
Why Henry Schein (HSIC) is a top value stock for the long term - MSN
Henry Schein Inc (HSIC) Stock Up 4.5% and Still Undervalued -- G - GuruFocus
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein One Releases 2026 Catalyst Index - Dentistry Today
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth - 01net
Henry Schein (HSIC) director boosts stake with 10,000-share open-market buy via trust - Stock Titan
Henry Schein beats Q1 earnings with $1.32 EPS, 6.3% revenue growth - eciks.org
Henry Schein : 2026 Proxy Supplement May 12, 2026 of 2025 - marketscreener.com
Right to Read, but Wrong to Write - Health API Guy
Henry Schein, Inc Receives Shareholder Proposal from John Chevedden - marketscreener.com
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein, Inc. $HSIC Holdings Increased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Henry Schein stock (US42548G1040): Dental and medical distributor reports Q1 results and raises outl - AD HOC NEWS
Henry Schein stock (US42548G1040): Q1 2026 results and buyback drive sentiment - AD HOC NEWS
Barclays Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $86 - Moomoo
Henry Schein tops expectations, but shares dip slightly after results - MSN
Henry Schein Inc stock (US8064071025): Dental and medical distributor reports Q1 results and raises - AD HOC NEWS
Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), Alphatec Holdings (ATEC) - The Globe and Mail
Number of shareholders of Henry Schein, Inc. – MIL:1HSIC - TradingView
Henry Schein Earnings Call Highlights Margin Momentum - The Globe and Mail
Henry Schein’s THRIVELIVE 2026 Delivers on Innovation, Education, and Inspiration - Dentistry Today
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Research Alert: CFRA Maintains Hold Rating On Shares Of Henry Schein - Moomoo
Henry Schein Still Sees 2026 Adjusted Ebitda Up Mid-Single Digits >HSIC - Moomoo
Here's why Henry Schein (HSIC) is a strong value stock - MSN
Transcript: Henry Schein Q1 2026 Earnings Conference Call - Sahm
UBS Adjusts Price Target on Henry Schein to $85 From $87, Maintains Neutral Rating - marketscreener.com
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein, Inc. (NASDAQ:HSIC) Q1 2026 Earnings Call Transcript - Insider Monkey
HSIC Q1 Deep Dive: Dental and Technology Strength Offset Medical Softness, Value Initiatives Underway - The Globe and Mail
Henry Schein Q1 Earnings Call Highlights - Yahoo Finance
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Piper Sandler Cuts Price Target on Henry Schein to $91 From $99 - marketscreener.com
Jefferies Adjusts Price Target on Henry Schein to $80 From $89, Maintains Hold Rating - marketscreener.com
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Henry Schein Inc Azioni (HSIC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Popeck Thomas C | CEO, Henry Schein Products |
Mar 19 '26 |
Sale |
72.79 |
1,355 |
98,630 |
86,182 |
0.00%
6.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):